**Core Concept**
Platelet aggregation is a crucial step in the formation of a blood clot, and it is regulated by various factors. **Antiplatelet agents** inhibit platelet aggregation, preventing thrombus formation. This process involves **platelet receptors**, **enzymes**, and **signaling pathways**.

**Why the Correct Answer is Right**
Since the correct answer is not explicitly provided, let's analyze the common inhibitors of platelet aggregation. **Aspirin** inhibits **cyclooxygenase** (COX), preventing the formation of **thromboxane A2**, a potent platelet aggregator. **Clopidogrel** blocks the **P2Y12 receptor**, inhibiting **ADP-mediated** platelet aggregation.

**Why Each Wrong Option is Incorrect**
**Option A:** Aspirin is a well-known inhibitor of platelet aggregation.
**Option B:** Clopidogrel also inhibits platelet aggregation by blocking the P2Y12 receptor.
**Option C:** **Dipyridamole** inhibits platelet aggregation by blocking the uptake of **adenosine** into platelets.

**Clinical Pearl / High-Yield Fact**
Inhibitors of platelet aggregation are commonly used to prevent **arterial thrombosis** in patients with **coronary artery disease** or **cerebrovascular disease**.

**Correct Answer:** D.